PCV44 COST ANALYSIS OF THE INTRODUCTION OF A SINGLE-PILL COMBINATION OF ROSUVASTATIN AND EZETIMIBE IN THE GREEK SETTING
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.769
https://www.valueinhealthjournal.com/article/S1098-3015(19)33147-X/fulltext
Section Title :
Section Order :
10667
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33147-X&doi=10.1016/j.jval.2019.09.769